MannKind Corporation Company Culture

MannKind Corporation Mission, Vision & Values

Sustainability and Corporate Social Responsibility at MannKind Corporation

A Thoughtful Approach to Benefit All
MannKind’s EH&S department is committed to identifying, reducing, and if practical, eliminating the use of any substance or material that may cause safety or environmental hazards. With a solutions-minded approach, they thoughtfully identify opportunities for continuous improvement in MannKind’s environmental health & safety practices.
LEED and Energy Star Certified Building
MannKind moved its West Coast operations in 2017 to a certified Energy Star, Silver LEED certification classification building in Westlake Village, Calif. that is equipped with electric vehicle (EV) charging stations available to employees.
Energy Conservation with Connecticut DEEP
Each year, we utilize energy to manufacture medicines that help people live life more humann. MannKind steadfastly remains within Connecticut Department of Energy and Environmental Protection (DEEP) guidelines to be responsible stewards of the environment.
As product demand increases, and as we continue to produce future medicines, the expectation is that production will increase, and energy use will naturally as well. This does not impede our efforts to reduce energy consumption and/or the transition to renewable energy sources.
General Recycling
MannKind’s manufacturing facility, Boston site and California office maintain recyclable waste programs, including paper, plastic, glass, metal, battery, and other materials.
Project Lightbulb
And no practice is too small or too large for consideration as MannKind’s Project Lightbulb proves at its Danbury facility. MannKind employs local State initiatives for replacing lightbulbs with more energy-saving light-emitting diodes (LEDs). Lightbulbs may sound small, but our manufacturing facility utilizes an estimated 10,000 lightbulbs, so replacements can be impactful.
Project Lightbulb continued in 2022 with the conversion of our Danbury facility’s parking lot light bulbs being converted to LED. This resulted in a 50% reduction in kilowatts of annual exterior electricity usage.
Waste Management and PiE
It is always our intention to minimize and properly dispose of waste that naturally accumulates from research, development and manufacturing of medicines, as well as general and administrative services. In addition, pharmaceuticals in the environment (PiE) can pose a public health risk. MannKind maintains strict disposal processes that are in compliance with the EPA Resource Conservation and Recovery Act (RCRA).
A multi-disciplinary team is constantly focused on proper waste management and reduction of all wastes, including solid, construction bulk, proprietary, biohazard, sharps, and more. MannKind also monitors stormwater catch basins to ensure run-off from the facility is clean and non-impactful to the environment.
Waste Reuse
In 2022, using our waste management system MannKind recycled approximately 46,000 lbs. of materials, including hazardous chemicals, metal, glass, cardboard, paper, light bulbs and e-waste. Additionally, we were able to partner with a hazardous waste hauler to be able to reuse more than 5,000 lbs. of spent liquids by fuel blending.
More than 130,000 lbs. of our waste in 2022 was recovered by the trash-to-energy process which is equivalent to generating 36,000 kw hours –or the electricity needed to power 3.5 average homes for one year.

Water Usage and Treatment System
Water is a valuable resource and MannKind treats it with respect. Water is a necessity in manufacturing medicines –whether it be for creating steam for humidification or for complying with intensive cleaning standards and guidelines.
In Danbury, water is sourced from the City for use throughout MannKind’s facility. Prior to discharge, process wastewater is treated on-site to ensure proper pH and temperature levels in accordance with CT Department of Energy and Environmental and Protection regulation. Once water is used, it is returned through Publicly Owned Treatment Works (POTW) for processing. MannKind maintains permits through the State of Connecticut to operate its water treatment system on-site and maintains records for government inspection and compliance.
In 2022, we installed a new Reverse Osmosis (RO) system in our Danbury manufacturing area. This improvement will reduce approximately 100,000 gallons of wastewater discharge per year.
PPE Reduction Project
Personal Protective Equipment (PPE) is a necessity at our manufacturing, research & development facility. In 2022, MannKind pinpointed a process project to reduce waste and excess chemical usage in our manufacturing area.
The project established new processes and protocols that not only maintained the utmost employee safety measures –but it resulted in a waste reduction of 75% in certain types of PPE. The shift also allowed for elimination of certain cleaning chemicals that were no longer required.

Community Engagement & Philanthropy
Doing right is a MannKind value and employees rally around the belief that it’s important to give back in the neighborhoods where we work and live as well as support the patient communities that we serve.
We encourage Mannitarian-driven philanthropy through volunteering and supporting local non-profits and causes that they are passionate about.
In 2022, employees enjoyed time with organizations such as Food Share, Salvation Army, Dorothy Day Hospitality House, the United Way of Western CT, and more.
MannKind also provides assistance to humanitarian disasters that impact communities where our employees reside, including support in response to the devastation and flooding experienced in Florida caused by Hurricane Ian. MannKind continued its efforts in 2022 supporting patient organizations such as JDRF, where we raised more than $30,000 for diabetes research via various team rides and walk events.